First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation

Mesenchymal stem cells and multipotent adult progenitor cells (MAPCs) have been proposed as novel therapeutics for solid organ transplant recipients with the aim of reducing exposure to pharmacological immunosuppression and its side effects. In the present study, we describe the clinical course of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem Cells Transl Med
Hauptverfasser: Soeder, Yorick, Loss, Martin, Johnson, Christian L., Hutchinson, James A., Haarer, Jan, Ahrens, Norbert, Offner, Robert, Deans, Robert J., Van Bokkelen, Gil, Geissler, Edward K., Schlitt, Hans J., Dahlke, Marc H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2015
Schlagworte:
Cell-Based Drug Development, Screening, and Toxicology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511146/
https://ncbi.nlm.nih.gov/pubmed/26041737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge